The NHS is restricting the use of cholinesterase inhibitors to those with moderate Alzheimer’s disease or worse. The efficacy data for mild dementia is minimal – with up to 30 to 50 percent showing no improvement.
ADVERTISEMENT
More in Uncategorized
Past Week
-
Why your clinic waiting room may affect patient outcomes
-
The human case for preserving the nipple after mastectomy
-
Nuclear verdicts and rising costs: How inflation is reshaping medical malpractice claims
-
How new loan caps could destroy diversity in medical education
-
The ethical crossroads of medicine and legislation
-
How community and buses saved my retirement
-
Past 6 Months
-
Health equity in Inland Southern California requires urgent action
-
Why transgender health care needs urgent reform and inclusive practices
-
How restrictive opioid policies worsen the crisis
-
Why primary care needs better dermatology training
-
New student loan caps could shut low-income students out of medicine
-
Why pain doctors face unfair scrutiny and harsh penalties in California
-
Recent Posts
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.
